Saba Al-Hashimi, MD
Ophthalmology Physician in Los Angeles, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,090 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Saba Al-Hashimi, MD reported a CMS MIPS final score of 74.6/100 - below the 83.1 national average - and filed 1,628 Medicare Part D claims in 2023.
- 74.6/100
- MIPS score · -9 vs avg
- 2K
- Part D claims, 2023
- 39%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Saba Al-Hashimi, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 12th percentile higher than 12% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Saba Al-Hashimi, MD sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Saba Al-Hashimi, MD writes more Part D claims than 63% of them and scores higher on MIPS quality than 13% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Saba Al-Hashimi, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Saba Al-Hashimi, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Saba Al-Hashimi, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Ophthalmology Physician compares to other specialties among California providers
Largest specialties in California (% of in-state providers)
Ophthalmology Physician ranks #47 among California's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Ophthalmology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Saba Al-Hashimi, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 74.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 74.6/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Ophthalmology Physician US NPIs
74.6/100 MIPS final score - 8.5 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 85. Cost dim: 30.2.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Saba Al-Hashimi, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 300 STEIN PLZ, Los Angeles, CA, 90095, with a listed phone of (310) 825-5501. NPI 1154687242 was issued on 04/03/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Al-Hashimi most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,628 prescription claims written by this provider, covering 353 Medicare beneficiaries and totaling roughly $271K in drug spend, split 61% brand-name and 39% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.6/100 for the 2023 performance year (Quality 85, Cost 30.2), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1154687242 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/03/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Saba Al-Hashimi, MD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Saba Al-Hashimi, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Saba Al-Hashimi, MD. Source: openpaymentsdata.cms.gov.
Total received
$255
Largest payer
Carl Zeiss Meditec USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Saba Al-Hashimi, MD. To verify Saba Al-Hashimi, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
61% brand-name claims vs 39% generic, on 1,628 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,502
- Total Day Supply
- 67,122
- Brand vs Generic
- 61% brand / 39% generic
- Brand Drug Cost
- $238K
- Generic Drug Cost
- $33K
Patient Demographics
- Average Patient Age
- 74.8 years
- Avg HCC Risk Score
- 1.80
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 24, 65-74: 141, 75-84: 143, 85+: 45
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Saba Al-Hashimi, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
557 claims
- Moxifloxacin
Moxifloxacin
235 claims
- Restasis 90
Restasis
90 claims
- Loteprednol Etabon… 89
Loteprednol Etabonate
89 claims
- Dorzolamide-Timolol 73
Dorzolamide-Timolol
73 claims
- Neomycin-Polymyxin… 45
Neomycin-Polymyxin-Dexameth
45 claims
- Valacyclovir 38
Valacyclovir
38 claims
- Cyclosporine 32
Cyclosporine
32 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 557 |
| Moxifloxacin Moxifloxacin Hcl | 235 |
| Restasis Cyclosporine | 90 |
| Loteprednol Etabonate | 89 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 73 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 45 |
| Valacyclovir Valacyclovir Hcl | 38 |
| Cyclosporine | 32 |
| Difluprednate | 31 |
| Xiidra Lifitegrast | 31 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Saba Al-Hashimi, MD fits within the Ophthalmology Physician landscape nationally.
Saba Al-Hashimi, MD's 1,628 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Al-Hashimi.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Saba Al-Hashimi, MD's specialty? ▼
How much does Saba Al-Hashimi, MD prescribe under Medicare Part D? ▼
What is Saba Al-Hashimi, MD's Medicare quality score? ▼
Where is Saba Al-Hashimi, MD located? ▼
What is Saba Al-Hashimi, MD's NPI number? ▼
Does Saba Al-Hashimi, MD prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does Saba Al-Hashimi, MD prescribe most often? ▼
Does Saba Al-Hashimi, MD accept Medicare? ▼
How can I verify Saba Al-Hashimi, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology